Could BCG be used to protect against COVID-19?
- PMID: 32341531
- PMCID: PMC7184546
- DOI: 10.1038/s41585-020-0325-9
Could BCG be used to protect against COVID-19?
Abstract
Nearly 100 years since it was first used in humans as a vaccine for tuberculosis, Bacillus Calmette–Guérin (BCG) has been suggested as a possible agent to prevent coronavirus disease 2019 (COVID-19). A number of studies are underway to investigate this possibility but — even if they prove effective — many questions will remain.
Conflict of interest statement
The author declares no competing interests.
Comment in
-
The effect of BCG vaccine in the era of COVID-19 pandemic.Scand J Immunol. 2020 Dec;92(6):e12947. doi: 10.1111/sji.12947. Epub 2020 Aug 27. Scand J Immunol. 2020. PMID: 32698247 Free PMC article. No abstract available.
References
-
- Colditz GA, et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics. 1995;96:29–35. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources